Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations

Research output: Contribution to journal › Article › Academic

Original language	Undefined/Unknown
Pages (from-to)	1-7
Number of pages	7
Journal	European Journal of Health Economics (HEPAC)
Volume	24
Publication status	Published - 2003

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{09131f3f070547b4ac2cc4647e859bf5,

title = "Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations",

author = "MJ Postma and JM Bos and R Welte and Ronald Groot and W Luytjes and HC R{\"u}mke and P Beutels",

year = "2003",

language = "Undefined/Unknown",

volume = "24",

pages = "1--7",

journal = "European Journal of Health Economics (HEPAC)",

issn = "1618-7601",

publisher = "Springer-Verlag",

}

TY - JOUR

T1 - Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations

AU - Postma, MJ

AU - Bos, JM

AU - Welte, R

AU - Groot, Ronald

AU - Luytjes, W

AU - Rümke, HC

AU - Beutels, P

PY - 2003

Y1 - 2003

M3 - Article

SN - 1618-7601

VL - 24

SP - 1

EP - 7

JO - European Journal of Health Economics (HEPAC)

JF - European Journal of Health Economics (HEPAC)

ER -